Purchase Order 36C26325P0149

Award Date 11/6/24
Potential Completion Date 12/6/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $34,000.00 firm-fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of transcatheter aortic valve replacement (TAVR) kits. The contract, which does not have a set-aside designation, has a completion date of May 20, 2024, and is part of the VA-VHA's efforts to provide specialized cardiovascular devices and services to support healthcare for veterans...
The Department of Veterans Affairs (VA) awarded a $34,000.00 firm-fixed price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the supply of TAVR (Transcatheter Aortic Valve Replacement) kits. The award, which has a completion date of March 20, 2025, is intended to support cardiovascular healthcare services at VA facilities across multiple Veterans Integrated Service Networks (VISNs). Edwards Lifesciences LLC is an experienced provider of specialized...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $34,000.00 firm fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company, for the delivery of TAVR (transcatheter aortic valve replacement) kits. The contract will support healthcare services at VA facilities within Veterans Integrated Service Network (VISN) 23. Edwards Lifesciences LLC has received numerous prime contract awards from...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company, for the provision of TAVR (Transcatheter Aortic Valve Replacement) kits. The $34,000 contract has a completion date of March 12, 2024 and will support healthcare services at VA facilities within Veterans Integrated Service Network (VISN) 23, located in Minneapolis,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of transcatheter aortic valve replacement (TAVR) products and related services. The $32,500 contract has an April 23, 2024 completion date and supports the VHA's Veterans Integrated Service Network (VISN) 23 serving the Minneapolis, MN area. Edwards Lifesciences LLC is a global leader in...
The U.S. Department of Veterans Affairs (VA) awarded a $45,000.00 firm fixed price purchase order contract to Edwards Lifesciences LLC, a for-profit limited liability company, for the delivery of prosthetic transcatheter aortic valve replacement (TAVR) devices. The contract has an ultimate completion date of February 22, 2025. Edwards Lifesciences LLC is a small disadvantaged business that has received numerous prime contract awards from the VA and Veterans Health Administration (VHA) to provide...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the supply of TAVR (transcatheter aortic valve replacement) heart valve implants. The contract has a potential value of $32,500.00 and a completion date of October 25, 2023. Edwards Lifesciences LLC is a subsidiary of Edwards Lifesciences Corporation and has received numerous prime contract awards from the VA...
This is a $32,500 firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a limited liability company and small disadvantaged business. The contract is for transcatheter aortic valve replacement (TAVR) products and services to support healthcare for veterans. The award has a completion date of June 11, 2024. Edwards Lifesciences LLC is a global leader in cardiovascular medical devices and has received numerous prime contracts from the VA...
The U.S. Department of Veterans Affairs (VA) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC, a for-profit limited liability company, for transcatheter aortic valve replacement (TAVR) services. The contract has a completion date of November 20, 2024 and does not utilize a set-aside designation. This award is part of Edwards Lifesciences LLC's broader work supporting the VA's Veteran Integrated Service Network (VISN) 23, which covers facilities in Minnesota. The...
The Department of Veterans Affairs Veterans Health Administration has awarded a $97,500.00 firm fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company, to provide TAVR (transcatheter aortic valve replacement) products to support urgent prosthetics needs for the Veterans Integrated Service Network 21 region. This order is not associated with a set-aside designation. Edwards Lifesciences LLC is a global leader in...

The Department of Veterans Affairs (VA) awarded a $34,000 firm-fixed price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of transcatheter aortic valve replacement (TAVR) kits. The award was made under the VA's Veterans Integrated Service Network 23 (VISN 23) and does not have a set-aside designation. Edwards Lifesciences LLC is a leading provider of specialized cardiovascular devices and related services to the VA and Veterans Health Administration (VHA) through prime and subcontract awards, including for products like Inspiris Resilia aortic valves, SAPIEN heart valves, and other transcatheter valve technologies. The contract has a completion date of December 6, 2024.

Generated 11/7/24, 9:15 AM